Pyridostigmine Bromide 60mg/5ml oral solution is formulated to manage muscle weakness associated with myasthenia gravis. By inhibiting acetylcholinesterase, it increases acetylcholine availability at the neuromuscular junction, enhancing nerve‑to‑muscle communication and improving strength and endurance. The liquid form allows precise titration and flexible dosing to support daily symptom control and functional mobility.
$430.00
| Active Ingredient | Pyridostigmine Bromide |
|---|---|
| Indication | Indicated for the symptomatic treatment of myasthenia gravis |
| Origin | United States of America |
| Packaging | 1 bottle (473 ml) |
| Storage Temperature | Controlled room temperature |
| Strength | 60mg/5ml |